{
    "nctId": "NCT05456373",
    "briefTitle": "Intraoperative Use of ClearEdge Device in Breast Conserving Surgery",
    "officialTitle": "Intraoperative Use of ClearEdge Device in Breast Conserving Surgery",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 288,
    "primaryOutcomeMeasure": "Percentage of subjects with positive margins post-op",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients who are female (genotype)\n2. Patients aged above 18 years, inclusive\n3. Patients diagnosed with breast DCIS or invasive cancer recommended for lumpectomy procedure\n4. Patients treated with neoadjuvant endocrine therapy may be enrolled\n\nExclusion Criteria:\n\n1. Patients currently receiving chemotherapy\n2. Patients having prior ipsilateral surgical treatment for breast cancer\n3. Patients who have had radiation therapy for ipsilateral breast cancer or for other malignancy that includes breast tissue in the radiation field (e.g. Hodgkin's lymphoma)\n4. Patients who have breast implants\n5. Patients who are pregnant and/or lactating\n6. Patients participating in other breast cancer studies involving surgical treatment to the breast in the past 6 months.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}